HYPNARA™
A passive structural implant
for the soft palate.
The near-term clinical wedge of the Somnus platform, for snoring and mild-to-moderate obstructive sleep apnea.
The mechanism
HYPNARA™ is a palatal implant that works the way a beam works: physical reinforcement of the soft palate, the tissue whose collapse drives snoring and much of mild-to-moderate OSA. The mechanism is structural and passive. The implant holds tissue. It does not compute, sense, or decide; there is no AI inside HYPNARA, and we describe it that way because that is what it is.
The intelligence in the Somnus platform lives in the software around the system: the sensing, scoring, and routing layers described across this site. The implant's job is simpler and older: hold the airway's shape.
The material
HYPNARA™ advances the palatal-implant approach with a change in implant material to UHMWPE (ultra-high-molecular-weight polyethylene, a material with a long record in implantable devices) engineered with a porous structure designed to support tissue ingrowth. The intent is an implant that doesn't merely sit in the palate but integrates with it.
Where HYPNARA sits in the loop
Somnus is building a closed-loop data network for upper airway dysfunction: sensing, scoring, routing, therapy, outcomes. HYPNARA™ is a therapy node in that loop. What makes the platform different is what happens after therapy: outcomes feed back into the network, re-scoring the patient over time.
Regulatory status
Pre-Submission complete (May 7). FDA confirmed the 510(k) pathway and our predicate device. Clinical study is next, as planned.
We publish status, not promises: no submission or clearance dates appear here until the study is scoped, because we do not publish dates we have not earned the right to publish.
Enter the loop.
HYPNARA™ is not yet FDA cleared and is not yet available for sale.